New drug approved_Ixazomib
USFDA recently approved Ixazomib, an antineoplastic agent.
Drug
name:
|
Ixazomib
|
Innovator:
|
Millennium Pharms
|
Brand
name:
|
Ninlaro®
|
Chemical
structure:
|
 1,3,2-dioxaborolane-4,4-diacetic acid,
2-[(1R)-1-[[2-[(2,5dichlorobenzoyl) amino] acetyl]amino]-3-methylbutyl]-5-oxo- |
Indications:
|
Ninlaro® is indicated in combination with
lenalidomide and dexamethasone for the treatment of patients with multiple
myeloma who have received at least one prior therapy.
|
Dosage
form:
|
Capsule; Oral
|
Strengths:
|
2.3mg; 3mg; 4mg
|
Comments
Post a Comment